Fund Snapshot from
ProShares Ultra Nasdaq BiotechnologyAdd to My Watchlist
BIB:USHealth & Biotechnology
- 100.28NAV
- 1.88 1.91%Prev Day's Change
- 2.02Beta vs SPX
- 0.95%Expense Ratio
- 52 Week Low - High
Fees & Expenses
| Front-End Load | -- |
| Back-End Load | 0.00 |
| Redemption Fee | 0.00 |
| Current Mgmt Fee | -- |
| 12b1 Fee | 0.00 |
| Total Expense Ratio | 0.95% |
Risk
| Standard Deviation | 31.37 |
| Sharpe Ratio | 3.94 |
Fund Profile
| ProShares Ultra Nasdaq Biotechnology is an an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to twice (200%) the return of the Nasdaq Biotechnology Index. | |
| Managers | HOWARD S RUBIN |
| TODD JOHNSON | |
| Inception Date | 4/7/10 |
| Web Site | www.proshares.com |
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.
